# Pappas Capital

> Pappas Capital is among the Top Healthcare Venture Capital Firms, focused on advancing biopharma, biotech, and medical technologies that improve patient outcomes\.

Generated by Yoast SEO v28.0, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [About Pappas Capital](https://www.pappas-capital.com/about-pappas-capital/)
- [Contact Pappas Capital](https://www.pappas-capital.com/contact-pappas-capital/)
- [Asia Innovation Ventures](https://www.pappas-capital.com/asia-innovation-ventures/)
- [Chiesi Ventures Fund](https://www.pappas-capital.com/chiesi-ventures/)
- [AgTech Initiatives](https://www.pappas-capital.com/ag-tech-innovations/)
- [For Entrepreneurs](https://www.pappas-capital.com/for-entrepreneurs/)
- [Pappas Portfolio](https://www.pappas-capital.com/portfolio/)
- [Pappas Ventures](https://www.pappas-capital.com/pappas-ventures/)
- [Providing Leadership for a World of Innovation\.](https://www.pappas-capital.com/)
- [Specialized Holdings](https://www.pappas-capital.com/specialized-holdings/)
- [Specialized Fund Management](https://www.pappas-capital.com/pappas-specialized-funds/)
- [Translational Medicine](https://www.pappas-capital.com/pappas-translational-medicine/)
- [Team](https://www.pappas-capital.com/team/)
- [Wake Forest Technology Development Program](https://www.pappas-capital.com/wake-forest-innovation-catalyst-fund/)

## Posts
- [NEZGLYAL® \(leriglitazone\) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy \(cALD\), a rare neurodegenerative disease](https://www.pappas-capital.com/nezglyal-leriglitazone-receives-a-positive-chmp-opinion-for-the-treatment-of-cerebral-adrenoleukodystrophy-cald-a-rare-neurodegenerative-disease/)
- [Aktis Oncology Reports First\-in\-Human Clinical Imaging and Dosimetry Data for AKY\-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7\-H3 Expressing Tumors](https://www.pappas-capital.com/aktis-oncology-reports-first-in-human-clinical-imaging-and-dosimetry-data-for-aky-2519-demonstrating-robust-tumor-uptake-and-limited-normal-tissue-exposures-in-patients-with-b7-h3-expressing-tumors/)
- [Aktis Oncology Initiates Phase 1b Clinical Trial for AKY\-2519, a B7\-H3 Miniprotein Radioconjugate, in Metastatic Castration\-Resistant Prostate Cancer \(mCRPC\)](https://www.pappas-capital.com/aktis-oncology-initiates-phase-1b-clinical-trial-for-aky-2519-a-b7-h3-miniprotein-radioconjugate-in-metastatic-castration-resistant-prostate-cancer-mcrpc/)
- [Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY\-2519](https://www.pappas-capital.com/aktis-oncology-announces-fda-clearance-of-investigational-new-drug-applications-for-aky-2519/)
- [Aktis Oncology Receives U\.S\. FDA Fast Track Designation for AKY\-1189, a Nectin\-4 Miniprotein Radioconjugate](https://www.pappas-capital.com/aktis-oncology-receives-u-s-fda-fast-track-designation-for-aky-1189-a-nectin-4-miniprotein-radioconjugate/)

## Popups
- [30 Years](https://www.pappas-capital.com/?post_type=popup&p=10758)
- [Example: Auto\-opening announcement popup](https://www.pappas-capital.com/?post_type=popup&p=10757)

## Popup Themes
- [Default Theme](https://www.pappas-capital.com/?post_type=popup_theme&p=10749)
- [Light Box](https://www.pappas-capital.com/?post_type=popup_theme&p=10750)
- [Enterprise Blue](https://www.pappas-capital.com/?post_type=popup_theme&p=10751)
- [Hello Box](https://www.pappas-capital.com/?post_type=popup_theme&p=10752)
- [Cutting Edge](https://www.pappas-capital.com/?post_type=popup_theme&p=10753)

## Portfolio
- [Achillion Pharmaceuticals](https://www.pappas-capital.com/portfolio-theme/achillion-pharmaceuticals/)

## Companies
- [IlluminOss Medical](https://www.pappas-capital.com/portfolio/illuminoss-medical/)
- [Allievex](https://www.pappas-capital.com/portfolio/allievex/)
- [Istari Oncology](https://www.pappas-capital.com/portfolio/istari-oncology/)
- [Solu Therapeutics](https://www.pappas-capital.com/portfolio/solu-therapeutics/)
- [Aer Therapeutics](https://www.pappas-capital.com/portfolio/aer-therapeutics/)

## Team Members
- [Art Pappas](https://www.pappas-capital.com/team_member/art-pappas-mba/)
- [Eoin McDonnell, PhD](https://www.pappas-capital.com/team_member/eoin-mcdonnell-ph-d/)
- [Antonio Chow](https://www.pappas-capital.com/team_member/antonio-chow/)
- [Bruce Sullenger, PhD](https://www.pappas-capital.com/team_member/bruce-sullenger-phd/)
- [Richard Staub](https://www.pappas-capital.com/team_member/richard-staub/)

## Categories
- [Uncategorized](https://www.pappas-capital.com/category/uncategorized/)
- [PV](https://www.pappas-capital.com/category/company-types/pv/)
- [Exits](https://www.pappas-capital.com/category/company-types/exits/)
- [Therapeutics](https://www.pappas-capital.com/category/company-types/aiv/)
- [Ultragenyx Pharmaceutical](https://www.pappas-capital.com/category/companies/ultragenyx-pharmaceutical/)

## Tags
- [press release](https://www.pappas-capital.com/tag/press-release/)
- [Ultragenyx](https://www.pappas-capital.com/tag/ultragenyx/)
- [CoLucid](https://www.pappas-capital.com/tag/colucid/)
- [TYRX](https://www.pappas-capital.com/tag/tyrx/)
- [Chimerix](https://www.pappas-capital.com/tag/chimerix/)

## Team Member Types
- [Venture Partners, Executives\-in\-Residence and Advisors](https://www.pappas-capital.com/team-member-type/venture-partners-executives-in-residence-and-advisors/)
- [Finance and Administration](https://www.pappas-capital.com/team-member-type/finance-and-administration/)
- [Partners](https://www.pappas-capital.com/team-member-type/partners/)
- [Investment Executives](https://www.pappas-capital.com/team-member-type/investment-executives/)

## Team Member Name
- [Ernie Mario](https://www.pappas-capital.com/team-member-name-type/ernie-mario/)
- [Richard Staub](https://www.pappas-capital.com/team-member-name-type/richard-staub/)
- [Glenda Crumpler](https://www.pappas-capital.com/team-member-name-type/glenda-crumpler/)
- [Karen LeVert](https://www.pappas-capital.com/team-member-name-type/karen-levert/)
- [Patrick Daly](https://www.pappas-capital.com/team-member-name-type/patrick-daly/)

## Optional
- [Sitemap index](https://www.pappas-capital.com/sitemap_index.xml)